biostudies-literatureMoura LMNICHD NIH HHSNCI NIH HHS685-694https://www.ebi.ac.uk/biostudies/studies/S-EPMC5117903biostudies-literatureUnknown8<h4>Objective</h4>Many effective medical therapies are available for treating neurological diseases, but these therapies tend to be expensive and adherence is critical to their effectiveness. We used patient-reported data to examine the frequency and determinants of financial barriers to medication adherence among individuals treated for neurological disorders.<h4>Patients and methods</h4>Patients completed cross-sectional surveys on iPads as part of routine outpatient care in a neurology clinic. Survey responses from a 3-month period were collected and merged with administrative sources of demographic and clinical information (eg, insurance type). We explored the association between patient characteristics and patient-reported failure to refill prescription medication due to cost in the previous 12 months, termed here as "nonadherence".<h4>Results</h4>The population studied comprised 6075 adults who were presented between July and September 2015 for outpatient neurology appointments. The mean age of participants was 56 (standard deviation: 18) years, and 1613 (54%) were females. The patients who participated in the surveys (2992, 49%) were comparable to nonparticipants with respect to gender and ethnicity but more often identified English as their preferred language (94% vs 6%, <i>p</i><0.01). Among respondents, 9.8% (n=265) reported nonadherence that varied by condition. These patients were more frequently Hispanic (16.7% vs 9.8% white, <i>p</i>=0.01), living alone (13.9% vs 8.9% cohabitating, <i>p</i><0.01), and preferred a language other than English (15.3% vs 9.4%, <i>p</i>=0.02).<h4>Conclusion</h4>Overall, the magnitude of financial barriers to medication adherence appears to vary across neurological conditions and demographic characteristics.ClinicoEconomics and outcomes research : CEORPatient-reported financial barriers to adherence to treatment in neurology.PMC5117903R01 HD075121R01 CA164023Schwamm LHMoura LMSeitz MPHsu JSchwamm ELMoura Junior VHoch DBfalsePatient-reported financial barriers to adherence to treatment in neurology.<h4>Objective</h4>Many effective medical therapies are available for treating neurological diseases, but these therapies tend to be expensive and adherence is critical to their effectiveness. We used patient-reported data to examine the frequency and determinants of financial barriers to medication adherence among individuals treated for neurological disorders.<h4>Patients and methods</h4>Patients completed cross-sectional surveys on iPads as part of routine outpatient care in a neurology clinic. Survey responses from a 3-month period were collected and merged with administrative sources of demographic and clinical information (eg, insurance type). We explored the association between patient characteristics and patient-reported failure to refill prescription medication due to cost in the previous 12 months, termed here as "nonadherence".<h4>Results</h4>The population studied comprised 6075 adults who were presented between July and September 2015 for outpatient neurology appointments. The mean age of participants was 56 (standard deviation: 18) years, and 1613 (54%) were females. The patients who participated in the surveys (2992, 49%) were comparable to nonparticipants with respect to gender and ethnicity but more often identified English as their preferred language (94% vs 6%, <i>p</i><0.01). Among respondents, 9.8% (n=265) reported nonadherence that varied by condition. These patients were more frequently Hispanic (16.7% vs 9.8% white, <i>p</i>=0.01), living alone (13.9% vs 8.9% cohabitating, <i>p</i><0.01), and preferred a language other than English (15.3% vs 9.4%, <i>p</i>=0.02).<h4>Conclusion</h4>Overall, the magnitude of financial barriers to medication adherence appears to vary across neurological conditions and demographic characteristics.2016-01-01T00:00:00Z20162025-04-04T09:21:01.841Z2019-03-27T02:29:27ZS-EPMC51179032789550610.2147/CEOR.S119971